Quick Answer
GeoVax Labs, Inc. reported R&D Expense of $23.71 million for fiscal year 2024.
GeoVax Labs, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2024 | $23.71M | +14.4% |
| 2023 | $20.72M | +127.1% |
| 2022 | $9.12M | -41.3% |
| 2021 | $15.55M | +536.3% |
| 2020 | $2.44M | +27.9% |
| 2019 | $1.91M | +1.7% |
| 2018 | $1.88M | -6.9% |
| 2017 | $2.02M | +2.4% |
| 2016 | $1.97M | +16.4% |
| 2015 | $1.69M | -6.6% |
| 2014 | $1.81M | -37.8% |
| 2013 | $2.91M | -4.2% |
| 2012 | $3.04M | -28.8% |
| 2011 | $4.28M | -10.8% |
| 2010 | $4.79M | +17.8% |
| 2009 | $4.07M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $5.04M | -31.9% | +6.7% |
| June 30, 2025 | $4.73M | +10.6% | -11.7% |
| March 31, 2025 | $5.35M | +21.0% | -27.7% |
| September 30, 2024 | $7.40M | +6.5% | +73.1% |
| June 30, 2024 | $4.28M | -9.4% | -3.4% |
| March 31, 2024 | $4.43M | +57.0% | -36.3% |
| September 30, 2023 | $6.95M | +155.3% | +47.2% |
| June 30, 2023 | $4.72M | +261.1% | +67.4% |
- GeoVax Labs, Inc. showed an increase of +14.4% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2024 period, GeoVax Labs, Inc.’s r&d expense has grown by 482.8% (from $4.07 million to $23.71 million).
- The most recent figure is from GeoVax Labs, Inc.’s fiscal year 2024 report (Form 10-K), filed with the SEC on March 27, 2025.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: